Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2014 / Articles / Nov / Sex Matters
Discovery & Development Clinical Trials

Sex Matters

New NIH policies aim to correct the sex bias in preclinical research

By Charlotte Barker 11/06/2014 0 min read

Share

Despite progress being made against sex bias in clinical studies, preclinical research often relies on male animals or cell lines. To tackle this disparity, the US National Institutes of Health (NIH) are making inclusion of male and female subjects mandatory in NIH-funded studies. Moreover, $10 million in supplemental grants is available to explore sex differences in ongoing preclinical research (1).

0214-203-upfront-main

We know that drugs can exhibit different rates of metabolism, efficacy and side effects in men and women.  “Examples abound of where failure to consider the impact of sex differences have led to harm and/or missed therapeutic opportunities,” says JoAnn Manson, Chief of the Division of Preventive Medicine, Brigham and Women’s Hospital, and Professor of Medicine.

There are also important differences in prevalence and outcomes between men and women in a whole host of common conditions. “Sex differences affect nearly all organ-systems, and differences are particularly prominent in the vascular/cardiac, endocrine, metabolic, brain/neurologic, immunologic, and respiratory systems,” explains Manson. In a recent retrospective study, researchers at Yale University found that among young heart attack patients, women had higher rates of in-hospital mortality, suffered more co-morbidities and stayed longer in hospital than men (2). In fact, the NIH has required the inclusion of women in all NIH-funded clinical research since 1993 – and just over half of clinical trial subjects in NIH-funded trials are now women. It makes sense to now turn the spotlight on preclinical studies, especially given a recent study of published preclinical research in surgery, which found that 22 percent of studies did not report the sex of the animals used and, of those that did, 80 percent used only male animals (17 percent used only females, and only 3 percent included both) (3). “The consideration of sex as a biologic variable in all forms of research is long overdue, and holds promise for new discoveries that will provide clinical benefits for the entire population,” concludes Manson.

References

  1. NIH Press Release, “New supplemental awards apply sex and gender lens to NIH-funded research”, 23 September (2014). www.nih.gov
  2. A. Gupta, Y. Wang, J.A. Spertus et al. “Trends in Acute Myocardial Infarction in Young Patients and Differences by Sex and Race, 2001 to 2010”, J. Am. Coll. Cardiol. 64(4), 337-345 (2014).
  3. D.Y. Yoon, N.A. Mansukhani, V.C. Stubbs et al. “Sex bias exists in basic science and translational surgical research”, Surgery 156 (3), 508–516 (2014).

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. NIH Press Release, “New supplemental awards apply sex and gender lens to NIH-funded research”, 23 September (2014). www.nih.gov
  2. A. Gupta, Y. Wang, J.A. Spertus et al. “Trends in Acute Myocardial Infarction in Young Patients and Differences by Sex and Race, 2001 to 2010”, J. Am. Coll. Cardiol. 64(4), 337-345 (2014).
  3. D.Y. Yoon, N.A. Mansukhani, V.C. Stubbs et al. “Sex bias exists in basic science and translational surgical research”, Surgery 156 (3), 508–516 (2014).

About the Author(s)

Charlotte Barker

As an Editor at Texere, I’m working closely with our audience to create vibrant, engaging content that reflects the hard work and passion that goes into bringing new medicines to market. I got my start in biomedical publishing as a commissioning editor for healthcare journals and have spent my career covering everything from early-stage research to clinical medicine, so I know my way around. And I can’t think of a more interesting, challenging or important area to be working in.

More Articles by Charlotte Barker

False

Advertisement

Recommended

False

Related Content

The (Un)fairer Sex?
Clinical Trials
The (Un)fairer Sex?

November 6, 2014

0 min read

Our understanding of the differences in male and female biology is constantly growing – but can we translate that knowledge into better healthcare for all?

Sex Matters
Clinical Trials
Sex Matters

November 6, 2014

0 min read

New NIH policies aim to correct the sex bias in preclinical research

Asking the Right Questions in R&D
Clinical Trials Contract Development Services Trends & Forecasts
Asking the Right Questions in R&D

March 6, 2025

3 min read

And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.

AI, Big Data, and Digital Disruption
Digital Technologies Clinical Trials
AI, Big Data, and Digital Disruption

March 31, 2025

7 min read

An industry survey looks at changing attitudes and challenges in digital innovation for clinical research. Uptake is slow but steady.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.